Skip to main content
user-generated· regulatory

FDA approves ultrasound TTTS treatment within 24 months

The FDA will grant 510(k) clearance for the non-invasive ultrasound procedure developed by Imperial College and Queen Charlotte's Hospital to treat TTTS, based on the success of follow-up trials and safety data. This approval will enable widespread clinical adoption in US hospitals.

regulatory · Prediction Market

Implied probability (Yes)
70%
Closes
2028-06-30

More regulatory markets

Browse all regulatory markets →

Loading…